| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnl(17p) in AML: who will guard the guardian?
|
Battiwalla, Minoo
|
|
|
123 |
19 |
p. 2906-2907
|
artikel
|
| 2 |
Adherence to the Mediterranean diet is associated with lower platelet and leukocyte counts: results from the Moli-sani study
|
Bonaccio, Marialaura
|
|
|
123 |
19 |
p. 3037-3044
|
artikel
|
| 3 |
A mouse model of HIES reveals pro- and anti-inflammatory functions of STAT3
|
Steward-Tharp, Scott M.
|
|
|
123 |
19 |
p. 2978-2987
|
artikel
|
| 4 |
Biology of tissue factor pathway inhibitor
|
Wood, Jeremy P.
|
|
|
123 |
19 |
p. 2934-2943
|
artikel
|
| 5 |
Bonetti P, Testoni M, Scandurra M, et al. Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma. Blood. 2013;122(13):2233-2241.
|
|
|
|
123 |
19 |
p. 3056
|
artikel
|
| 6 |
Bortezomib resistance and MUC1 in myeloma
|
Grant, Steven
|
|
|
123 |
19 |
p. 2910-2912
|
artikel
|
| 7 |
CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets
|
Gleason, Michelle K.
|
|
|
123 |
19 |
p. 3016-3026
|
artikel
|
| 8 |
Cellular origin of T-cell lymphomas
|
de Leval, Laurence
|
|
|
123 |
19 |
p. 2909-2910
|
artikel
|
| 9 |
Eckhardt CL, van Velzen AS, Peters M, et al. Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A. Blood. 2013;122(11):1954-1962.
|
|
|
|
123 |
19 |
p. 3056
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
123 |
19 |
p. i
|
artikel
|
| 11 |
GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features
|
Wang, Tianjiao
|
|
|
123 |
19 |
p. 3007-3015
|
artikel
|
| 12 |
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
|
Iqbal, Javeed
|
|
|
123 |
19 |
p. 2915-2923
|
artikel
|
| 13 |
Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice
|
Newman, Robert G.
|
|
|
123 |
19 |
p. 3045-3055
|
artikel
|
| 14 |
HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy
|
Fajgenbaum, David C.
|
|
|
123 |
19 |
p. 2924-2933
|
artikel
|
| 15 |
Indolent and mantle cell NHL: the future is BRIGHT
|
Fowler, Nathan
|
|
|
123 |
19 |
p. 2905-2906
|
artikel
|
| 16 |
Mosquito-borne enigma
|
Lum, Lionel Hon Wai
|
|
|
123 |
19 |
p. 2913
|
artikel
|
| 17 |
New regulatory role for SRF in neutrophils
|
Filippi, Marie-Dominique
|
|
|
123 |
19 |
p. 2903-2904
|
artikel
|
| 18 |
Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma
|
Kolstad, Arne
|
|
|
123 |
19 |
p. 2953-2959
|
artikel
|
| 19 |
Oaks JJ, Santhanam R, Walker CJ, et al. Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies. Blood. 2013;122(11):1923-1934.
|
|
|
|
123 |
19 |
p. 3056
|
artikel
|
| 20 |
Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
|
Middeke, Jan M.
|
|
|
123 |
19 |
p. 2960-2967
|
artikel
|
| 21 |
Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study
|
Flinn, Ian W.
|
|
|
123 |
19 |
p. 2944-2952
|
artikel
|
| 22 |
Rapidly progressive neurological deterioration without magnetic resonance imaging abnormalities: intravascular lymphoma
|
van Rhenen, Anna
|
|
|
123 |
19 |
p. 2914
|
artikel
|
| 23 |
Runx1 and Cbfβ regulate the development of Flt3+ dendritic cell progenitors and restrict myeloproliferative disorder
|
Satpathy, Ansuman T.
|
|
|
123 |
19 |
p. 2968-2977
|
artikel
|
| 24 |
SRF is required for neutrophil migration in response to inflammation
|
Taylor, Ashley
|
|
|
123 |
19 |
p. 3027-3036
|
artikel
|
| 25 |
Targeting MUC1-C is synergistic with bortezomib in downregulating TIGAR and inducing ROS-mediated myeloma cell death
|
Yin, Li
|
|
|
123 |
19 |
p. 2997-3006
|
artikel
|
| 26 |
The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells
|
Zhang, Jenny
|
|
|
123 |
19 |
p. 2988-2996
|
artikel
|
| 27 |
The right “Job” for STAT3 mutant mice!
|
Tangye, Stuart G.
|
|
|
123 |
19 |
p. 2907-2909
|
artikel
|
| 28 |
Warsch W, Walz C, Sexl V. JAK of all trades: JAK2-STAT5 as novel therapeutic targets in BCR-ABL1 + chronic myeloid leukemia. Blood. 2013;122(13):2167-2175.
|
|
|
|
123 |
19 |
p. 3056
|
artikel
|
Tijdschrift beschrijving